Prostaglandin E2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1833-1841

  Bai, Xiaoming ^a   Wang, Jie ^a   Zhang, Li ^a   Ma, Juan ^a   Zhang, Hai ^a   Xia, Shukai ^a   Zhang, Min ^a   Ma, Xiuping ^b   Guo, Yan ^a   Rong, Rong ^c   Cheng, Shanyu ^a   Shu, Wei ^d   Wang, Yipin ^a   Leng, Jing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d Jiangsu Province Engineering Research Center of Stomatological Translational Medicine   (China)

Author keywords

Cell adhesion; EP1 receptor; Focal adhesion kinase; Hepatocellular carcinoma; Migration

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; FOCAL ADHESION KINASE; PROSTAGLANDIN E RECEPTOR 1; PROTEIN KINASE C; PROTEIN KINASE P60;

ARTICLE; CELL ADHESION; CELL MIGRATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DINOPROSTONE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; SIGNAL TRANSDUCTION;

EID: 84875978959     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1859     Document Type: Article

References (51)

1. Wu T: Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treat Rev 32: 28-44, 2006. (Pubitemid 43159775)
2. Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H and Koike K: Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 117: 4475-4483, 2011.
3. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann Surg Oncol 15: 962-971, 2008.
4. Mon NN, Ito S, Senga T and Hamaguchi M: FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann NY Acad Sci 1086: 199-212, 2006. (Pubitemid 47084387)
5. Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY and Fu SB: Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 101: 327-334, 2009.
6. Kwiatkowska A, Kijewska M, Lipko M, Hibner U and Kaminska B: Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates mMPs expression. Biochim Biophys Acta 1813: 655-667, 2011.
7. Chan KT, Cortesio CL and Huttenlocher A: FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 185: 357-370, 2009.
8. Guan JL: Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 62: 268-276, 2010.
9. Mitra SK and Schlaepfer DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523, 2006. (Pubitemid 44332916)
10. Yuan Z, Zheng Q, Fan J, Ai KX, Chen J and Huang XY: Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma. J Cancer Res Clin Oncol 136: 1489-1496, 2010.
11. Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W and Bi J: FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27: 71-82, 2010.
12. Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H and Leng J: Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells. Oncol Rep 21: 129-136, 2009.
13. Xia D, Wang D, Kim SH, Katoh H and DuBois RN: Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 18: 224-226, 2012.
14. Harding P and LaPointe MC: Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor. Prostaglandins Leukot Essent Fatty Acids 84: 147-152, 2011.
15. Kim JI, Lakshmikanthan V, Frilot N and Daaka Y: Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol Cancer Res 8: 569-577, 2010.
16. Wu J, Zhang Y, Frilot N, Kim JI, Kim WJ and Daaka Y: Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway. J Biol Chem 286: 33954-33962, 2011.
17. Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neuschäfer-Rube F, Püschel GP, Metters KM and Abramovitz M: Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 340: 227-241, 1997. (Pubitemid 28022647)
18. O'Callaghan G, Kelly J, Shanahan F and Houston A: Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. Br J Cancer 99: 502-512, 2008.
19. Rundhaug JE, Simper MS, Surh I and Fischer SM: The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev 30: 465-480, 2011.
20. Liu H, Xiao J, Yang Y, Liu Y, Ma R, Li Y, Deng F and Zhang Y: COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res 82: 131-140, 2011.
21. Han C, Michalopoulos GK and Wu T: Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207: 261-270, 2006.
22. Liu JF, Fong YC, Chang CS, Huang CY, Chen HT, Yang WH, Hsu CJ, Jeng LB, Chen CY and Tang CH: Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells. Mol Cancer 9: 43, 2010.
23. Bai XM, Jiang H, Ding JX, Peng T, Ma J, Wang YH, Zhang L, Zhang H and Leng J: Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells. Life Sci 86: 214-223, 2010.
24. Leng J, Han C, Demetris AJ, Michalopoulos GK and Wu T: Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38: 756-768, 2003. (Pubitemid 37052162)
25. Wendum D, Masliah J, Trugnan G and Fléjou JF: Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch 445: 327-333, 2004. (Pubitemid 39517756)
26. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB and De Marzo AM: Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215: 1-20, 2004. (Pubitemid 39221453)
27. Alfranca A, López-Oliva JM, Genís L, López-Maderuelo D, Mirones I, Salvado D, Quesada AJ, Arroyo AG and Redondo JM: PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway. Blood 112: 1120-1128, 2008.
28. Zhang Y and Daaka Y: PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. Blood 118: 5355-5364, 2011.
29. Cui W, Yu CH and Hu KQ: In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Clin Cancer Res 11: 8213-8221, 2005. (Pubitemid 41698767)
30. Wu T, Leng J, Han C and Demetris AJ: The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther 3: 299-307, 2004. (Pubitemid 39193705)
31. Boonmasawai S, Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S and Palo T: Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture. J Med Assoc Thai 92: 1508-1515, 2009.
32. Tsai WC, Hsu CC, Chou SW, Chung CY, Chen J and Pang JH: Effects of celecoxib on migration, proliferation and collagen expression of tendon cells. Connect Tissue Res 48: 46-51, 2007. (Pubitemid 46371978)
33. Thorat MA, Morimiya A, Mehrotra S, Konger R and Badve SS: Prostanoid receptor EP1 expression in breast cancer. Mod Pathol 21: 15-21, 2008.
34. Han C and Wu T: Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 280: 24053-24063, 2005. (Pubitemid 40884893)
35. Surh I, Rundhaug JE, Pavone A, Mikulec C, Abel E, Simper M and Fischer SM: The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors. Mol Carcinog 51: 553-564, 2011.
36. Yang SF, Chen MK, Hsieh YS, Chung TT, Hsieh YH, Lin CW, Su JL, Tsai MH and Tang CH: Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J Biol Chem 285: 29808-29816, 2010.
37. Yamamoto D, Sonoda Y, Hasegawa M, Funakoshi-Tago M, Aizu-Yokota E and Kasahara T: FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways. Cell Signal 15: 575-583, 2003. (Pubitemid 36385163)
38. von Sengbusch A, Gassmann P, Fisch KM, Enns A, Nicolson GL and Haier J: Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol 166: 585-596, 2005. (Pubitemid 40189054)
39. Hess AR and Hendrix MJ: Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle 5: 478-480, 2006. (Pubitemid 43340521)
40. Cox BD, Natarajan M, Stettner MR and Gladson CL: New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99: 36-52, 2006. (Pubitemid 44297948)
41. Bosco R, Melloni E, Celeghini C, Rimondi E, Vaccarezza M and Zauli G: Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. Mini Rev. Med Chem 11: 185-199, 2011.
42. Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K and Parker PJ: PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol 11: 103-112, 2010.
43. Wu TT, Hsieh YH, Wu CC, Hsieh YS, Huang CY and Liu JY: Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Clin Chim Acta 382: 54-58, 2007.
44. Wu TT, Hsieh YH, Hsieh YS and Liu JY: Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 103: 9-20, 2008.
45. Siesser PM and Hanks SK: The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12: 3233-3237, 2006.
46. Lau GM, Lau GM, Yu GL, Gelman IH, Gutowski A, Hangauer D and Fang JW: Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci 54: 1465-1474, 2009.
47. Fischer OM, Hart S, Gschwind A and Ullrich A: EGFR signal transactivation in cancer cells. Biochem Soc Trans 31: 1203-1208, 2003. (Pubitemid 38030939)
48. Buchanan FG, Wang D, Bargiacchi F and DuBois RN: Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278: 35451-35457, 2003. (Pubitemid 37102315)
49. Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A and Arteaga CL: Transforming growth factor β induces clustering of HER2 and integrins by activating Src-FAK and receptor association to the cytoskeleton. Cancer Res 69: 475-482, 2009.
50. Aponte M, Jiang W, Lakkis M, Li MJ, Edwards D, Albitar L, Vitonis A, Mok SC, Cramer DW and Ye B: Activation of PAF-receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/Paxillin in ovarian cancer. Cancer Res 68: 5839-5848, 2008.
51. Calandrella SO, Barrett KE and Keely SJ: Transactivation of the epidermal growth factor receptor mediates muscarinic stimulation of focal adhesion kinase in intestinal epithelial cells. J Cell Physiol 203: 103-110, 2005. (Pubitemid 40328177)